Best papers

AuthorsTitlePubmedBasic ScienceClinical ScienceSocial Science
Thijs Reyniers, Christiana Nöstlinger, Marie Laga, Irith De Baetselier, Tania Crucitti, Kristien Wouters, Bart Smekens, Jozefien Buyze, Bea VuylstekeChoosing Between Daily and Event-Driven Pre-exposure Prophylaxis: Results of a Belgian PrEP Demonstration ProjectJ Acquir Immune Defic Syndr. 2018 Oct 1;79(2):186-194. x 
Tessa Goetghebuer, Kinga K Smolen,  Catherine Adler, Jishnu Das, Trevor McBride, Gaby Smits,  Sandra Lecomte, Edwige Haelterman, Patricia Barlow, Pedro A Piedra,  Fiona van der Klis, Tobias R Kollmann, Douglas A Lauffenburger,  Galit Alter,  Jack Levy, Arnaud MarchantInitiation of anti-retroviral therapy before pregnancy reduces the risk of infection-related hospitalization in HIV-exposed uninfected infants born in a high-income countryClin Infect Dis. 2018 Sep 12.  x 
P. Pannus, P. Adams, E. Willems, L. Heyndrickx, E. Florence, S. Rutsaert, W. De Spiegelaere, L. Vandekerckhove, C. Seguin-Devaux, G. VanhamIn-vitro viral suppressive capacity correlates with immune checkpoint marker expression on peripheral CD8+ T cells in treated HIV positive patientsAIDS July 13th 2018  x  
Leïla Belkhir, Carole Seguin-Devaux, Laure Elens, Caroline Pauly, Nicolas Gengler, Serge Schneider, Jean Ruelle, Vincent Haufroid & Bernard VandercamImpact of UGT1A1 polymorphisms on Raltegravir and its glucuronide plasma concentrations in a cohort of HIV-1 infected patientsSci Rep. 2018 May 9;8(1):7359.  x 
Darcis G, Lambert I, Sauvage AS, Frippiat F, Meuris C, Uurlings F, Lecomte M, Léonard P, Giot JB, Fombellida K, Vaira D, Moutschen M.Factors associated with late presentation for HIV care in a single Belgian reference center: 2006-2017.Sci Rep. 2018 Jun 5;8(1):8594. doi: 10.1038/s41598-018-26852-0. x 
De Voeght A, Martens H, Renard C, Vaira D, Debruche M, Simonet J, Geenen V, Moutschen M, Darcis G.Exploring the link between innate immune activation and thymic function by measuring sCD14 and TRECs in HIV patients living in Belgium.

PLoS One. 2017 Oct 19;12(10):e0185761. doi: 10.1371/journal.pone.0185761. eCollection 2017.x  
Mortier V, Demecheleer E, Staelens D, Schauvliege M, Dauwe K, Dinakis S, Hebberecht L, Vancoillie L, Verhofstede C.Quantification of total HIV-1 DNA in buffy coat cells, feasibility and potential added value for clinical follow-up of HIV-1 infected patients on ART.J Clin Virol. 2018 Sep;106:58-63.x  
Mortier V, Vancoillie L, Dauwe K, Staelens D, Demecheleer E, Schauvliege M, Dinakis S, Van Maerken T, Dessilly G, Ruelle J, Verhofstede C.Meticulous plasma isolation is essential to avoid false low-level viraemia in Roche Cobas HIV-1 viral load assays.Antivir Ther. 2018;23(3):277-281.x  
Hebberecht L, Vancoillie L, Schauvliege M, Staelens D, Dauwe K, Mortier V, Verhofstede CFrequency of occurrence of HIV-1 dual infection in a Belgian MSM population.PLoS One. 2018 Apr 6;13(4):e0195679.  x 
Verhofstede C, Dauwe K, Fransen K, Van Laethem K, Van den Wijngaert S, Ruelle J, Delforge ML, Vancutsem E, Vaira D, Stoffels K, Ribas SG, Dessilly G, Debaisieux L, Pierard D, Van Ranst M, Hayette MP, Deblonde J, Sasse A, Van Beckhoven D, Mortier V.Phylogenetic analysis of the Belgian HIV-1 epidemic reveals that local transmission is almost exclusively driven by men having sex with men despite presence of large African migrant communities.Infect Genet Evol. 2018 Jul;61:36-44. x 
Verhofstede C, Fransen K, Van Den Heuvel A, Van Laethem K, Ruelle J, Vancutsem E, Stoffels K, Van den Wijngaert S, Delforge ML, Vaira D, Hebberecht L, Schauvliege M, Mortier V, Dauwe K, Callens S.Decision tree for accurate infection timing in individuals newly diagnosed with HIV-1 infection.BMC Infect Dis. 2017 Nov 29;17(1):738. x 
Dauby N, Martin C, Hainaut M, Grammens T, Van den Wijngaert S, Delforge M, De Wit S.Prevalence and risk factors of measles seronegativity in a cohort of HIV-positive subjects: a retrospective study.HIV Med. 2018 Jul;19(6):426-429. x 
Libois A, Florence E, Derdelinckx I, Yombi JC, Henrard S, Uurlings F, Vandecasteele S, Allard SD, Demeester R, Van Wanzeele F, Ausselet N, De Wit S.Belgian guidelines for non-occupational HIV post-exposure prophylaxis 2017.
Acta Clin Belg. 2018 Aug;7 x 
Malinverni S, Gennotte AF, Schuster M, De Wit S, Mols P, Libois A.Adherence to HIV post-exposure prophylaxis: A multivariate regression analysis of a 5 years prospective cohort.J Infect. 2018 Jan;76(1):78-85 x 
Martin C, Castaigne C, Vierasu I, Garcia C, Wyndham-Thomas C, de Wit S.Prospective Serial FDG PET/CT During Treatment of Extrapulmonary Tuberculosis in HIV-Infected Patients: An Exploratory Study.
Clin Nucl Med. 2018 Sep;43(9) x 
Martin C, Payen MC, De Wit S.Dolutegravir as a trigger for DRESS syndrome?
Int J STD AIDS. 2018 Sep;29(10):1036-1038. x 
De Wit S, Florence E, Vandekerkhove L, Goffard JC, Vandercam B, Van Wijngaerden E, Moutschen M, Demeester R, Lacor P, Delforge M, van Frankenhuijsen M, Lacante P.Long-term treatment with atazanavir (ATV) in real life in Belgium: a retrospective observational cohort of 2264 HIV patients.

Acta Clin Belg. 2018 May 2:1-8.  x 
De Wit S, Florence E, Vandekerckhove L, Vandercam B, Goffard JC, Van Wijngaerden E, Moutschen M, Demeester R, Thilakarathne P, Piryns H; BREACH* Consortium.Long-term use of darunavir/ritonavir-containing regimens in daily practice in Belgium: retrospective observational cohort data of 1701 HIV-patients.

Acta Clin Belg. 2018 Oct;73(5):341-347 x